Winton Group LTD Kymera Therapeutics, Inc. Transaction History

Winton Group LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$14.13 - $42.55 $132,595 - $399,289	-9,384 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$35.3 - $64.68 $86,167 - $157,883	2,441 Added 35.16%	9,384 $397,000
Q4 2021 Feb 10, 2022	SELL	$49.91 - $65.56 $46,665 - $61,298	-935 Reduced 11.87%	6,943 $441,000
Q3 2021 Oct 28, 2021	BUY	$47.8 - $66.66 $110,179 - $153,651	2,305 Added 41.36%	7,878 $463,000
Q2 2021 Aug 10, 2021	BUY	$31.08 - $51.95 $173,208 - $289,517	5,573 New	5,573 $270,000

184

64.4M

50.6K

81.7K

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.2B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.